-
Esophageal adenocarcinoma (EAC), GERD, and Barretts esophagus (BE) are all on the rise, and there is no doubt that BE is a major risk factor for EAC. However, many unanswered questions surround screening GERD patients for BE and cancer.
-
Physical symptoms are quite common among patients with depression. These symptoms tend to improve during the first month of therapy with serotonin-antagonists. Most symptoms will plateau in months to follow.
-
Greenfield RH. Behind the banning of ephedra: Misuse, abuse, and dangers. Altern Med Alert 2004;7(3):25-33.
-
-
Q&A: Food and Drug Administration's actions on dietary supplements containing ephedrine alkaloids. Altern Med Alert 2004;7(3 Suppl):S1-S2.
-
Greenfield RH. Fat intake and breast cancer risk. Altern Med Alert 2004;7(3):36.
-
Kim YH. Mindulness meditation and chronic pain. Altern Med Alert 2004;7(3):33-35.
-
FDA has approved a long-acting implant for the palliative treatment of prostate cancer.
-
Studies on HCV infection resolution show that PBMC HCV-RNA may remain, despite clearance of the virus from plasma.
-
Exenatide (Extendin-4) significantly lowered HbA1C and caused weight loss in type 2 diabetes patients.
